Rhumbline Advisers Sera Prognostics, Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 39,970 shares of SERA stock, worth $125,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,970
Previous 39,970
-0.0%
Holding current value
$125,905
Previous $141,000
4.26%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SERA
# of Institutions
78Shares Held
23.7MCall Options Held
300Put Options Held
800-
Baker Bros. Advisors LP New York, NY5.5MShares$17.3 Million0.24% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$9.55 Million0.23% of portfolio
-
Interwest Venture Management CO2.42MShares$7.61 Million21.78% of portfolio
-
Abrdn PLC2.23MShares$7.02 Million0.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$5.2 Million1.65% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $93.2M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...